| AS | Ashworth Scale |
| BoNT | botulinum neurotoxin |
| DAS | Disability Assessment Scale |
| Dbar | posterior mean of the residual deviance |
| DIC | Deviance Information Criterion |
| EQ-5D | Quality-of-Life Scale |
| EMG | electromyography |
| ES | electrical stimulation |
| f | female |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| m | male |
| MAS | Modified Ashworth Scale |
| MCMC | Markov Chain Monte Carlo |
| MD | mean difference |
| MNP | manual needle placement |
| n | number |
| NA | not available |
| NMA | Network meta-analysis model |
| pD | effective degrees of freedom |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROM | ankle passive dorsiflexion range of motion |
| RCT | Randomized controlled trial |
| RoB 2 tool | revised Cochrane risk-of-bias tool for randomized studies |
| RMS-EMG | root mean square of surface electromyographic activity during the Ashworth maneuver |
| RT | Randomized trial |
| sd/SD | standard deviation |
| SUCRA | surface under the cumulative ranking curve |
| TCA | Tardieu catch angle |
| TSA | Tardieu spasticity angle |
| U | units |
| UME | unrelated mean effect |
| US | ultrasound |
| w | week |
| 10 mWT | 10 m walking test |
| 95% CrI | Credible interval |